Literature DB >> 29714424

[Genetic genes associated with oligospermia, asthenospermia and teratospermia: Advances in studies].

Ke Gao1, Zhi-Qiang Wang2, Xing-Chen Liu1, Zhi-Long Dong1, Wen-Sheng Shan2.   

Abstract

Approximately 2,300 genes are found to be associated with spermiogenesis and their expressions play important roles in the regulation of spermiogenesis. In recent years, more and more attention has been focused on the studies of the genes associated with oligospermia, asthenospermia and teratospermia and their molecular mechanisms. Some genes, such as GSTM1, DNMT3L, and CYP1A1, have been shown to be potentially associated with oligospermia; some, such as CATSPER1, CRISP2, SEPT4, TCTE3, TEKT4, and DNAH1, with asthenospermia; and still others, such as DPY19L2 and AURKC, with teratospermia. These findings have provided a molecular basis for the studies of the pathogenesis of oligospermia, asthenospermia and teratospermia, as well as a new approach to the exploration of new diagnostic and therapeutic techniques.

Entities:  

Keywords:  asthenospermia; gene; oligospermia; teratozoospermia

Mesh:

Substances:

Year:  2017        PMID: 29714424

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  3 in total

1.  Effects of L-carnitine combined with pancreatic kininogenase on thioredoxin 2, thioredoxin reductase 1, and sperm quality in patients with oligoasthenospermia.

Authors:  Yang Wang; Rui Zhang; Weijun Pan; Zhe Xu; Huan Yang; Qi Luo; Xiping Ye; Xianfeng Cheng
Journal:  Transl Androl Urol       Date:  2021-08

Review 2.  Stem Cell Therapies for Human Infertility: Advantages and Challenges.

Authors:  Jin-Xiang Wu; Tian Xia; Li-Ping She; Shu Lin; Xiang-Min Luo
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064

3.  Compound Xuanju Capsule combined with western medicine for the treatment of male oligoasthenotspermia: A protocol for systematic review and meta-analysis.

Authors:  Lili Chen; Hongyi Lan; Yuyan Zhang; Xiaoyan Zhang; Yu Liu
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.